Nanexa–Novo Nordisk PharmaShell Deal: From Validation to Development | Lucid Diligence Brief
This Lucid Diligence Brief examines the Nanexa–Novo Nordisk PharmaShell deal…
Basecamp Research $140M Series C: The Translation Test | Lucid Diligence Brief
This Lucid Diligence Brief examines Basecamp Research’s $140M Series C and…
Hematology Strategic Roundup | July 13 – August 14, 2026
Hematology Strategic Roundup exploring Key Developments and Competitive Shifts……
Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief
Johnson & Johnson's $1 billion Firefly Bio acquisition highlights a…
Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief
Harbour BioMed partners with Sinopharm to establish an innovation consortium…
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…
Public Health Strategic Roundup | June 11–July 15, 2026
Key Strategic Developments Shaping Public Health Coverage: June 11–July 15,…
Haisco Lilly Collaboration | Lucid Diligence Brief
Haisco’s Lilly Deal Tests China-Originated Small-Molecule Discovery…
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC Pipeline
Lucid Diligence Brief: Gilead To Acquire Tubulis to Expand Oncology ADC…
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1 asset
Lucid Diligence Brief: Ambrosia Biosciences $100M Series B for oral GLP-1……
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on…